Dendritic Cells Pulsed with Exosomes in Combination with PD-1 Antibody Increase the Efficacy of Sorafenib in Hepatocellular Carcinoma Model()()

Advanced hepatocellular carcinoma (HCC) has limited therapeutic options. Immunotherapy is a promising treatment, while sorafenib is a first-line drug-based treatment for advanced HCC. However, the efficacy of sorafenib and immunotherapy in combination, have not been clearly evaluated. Sorafenib trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Shengbin, Rao, Quan, Zhang, Chuangnian, Zhang, Xiuyuan, Qin, Yibo, Niu, Zuoxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789129/
https://www.ncbi.nlm.nih.gov/pubmed/29413757
http://dx.doi.org/10.1016/j.tranon.2018.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789129/
https://www.ncbi.nlm.nih.gov/pubmed/29413757
http://dx.doi.org/10.1016/j.tranon.2018.01.001

Ejemplares similares